Results 41 to 50 of about 855,465 (305)

Antiplatelet therapy for the prevention of atherosclerosis in chronic kidney disease (ALTAS-CKD) patients: study protocol for a randomized clinical trial

open access: yesTrials, 2021
Background Cardiovascular disease (CVD) is the most common complication and the leading cause of death in patients with chronic kidney disease (CKD).
Jiachuan Xiong   +11 more
doaj   +1 more source

Bone Disease in Chronic Kidney Disease and Kidney Transplant

open access: yesNutrients, 2022
Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) comprises alterations in calcium, phosphorus, parathyroid hormone (PTH), Vitamin D, and fibroblast growth factor-23 (FGF-23) metabolism, abnormalities in bone turnover, mineralization, volume, linear growth or strength, and vascular calcification leading to an increase in bone fractures and ...
Bellorin-Font, Ezequiel   +2 more
openaire   +2 more sources

Impact of hemodialysis solutions containing different levels of molecular hydrogen (H2) on the patient-reported outcome of fatigue

open access: yesRenal Replacement Therapy, 2022
Background Reportedly, dialysis solutions containing molecular hydrogen (H2) might ameliorate patient-reported fatigue in hemodialysis (HD) patients. However, it is unknown whether its impact might differ with different H2 levels. Method This single-arm,
Susumu Uemura   +8 more
doaj   +1 more source

Valvular heart disease in patients with chronic kidney disease [PDF]

open access: yes, 2022
Valvular heart disease (VHD) is highly prevalent in patients with chronic kidney disease (CKD) from the early stages to end-stage renal disease (ESRD).
O'Driscoll, Jamie M   +2 more
core   +1 more source

Sociodemographic characteristics and clinical features of patients with adult polycystic kidney disease undergoing hemodialysis [PDF]

open access: yes, 2013
Aims: To analyze the socio-demographic and clinical characteristics of patients with adult polycystic kidney disease admitted to hemodialysis services in Northwestern Paraná state, Brazil.
Tsuneto, Luiza Tamie   +13 more
core   +1 more source

韩国2型糖尿病患者谷氨酸升高与纤溶酶原水平升高有关

open access: yesJournal of Diabetes, 2023
Background Glutamate is a major neurotransmitter, although it causes cytotoxicity and inflammation in nonneuronal organs. This study aimed to investigate the metabolic disorders in which glutamate, associated with type 2 diabetes onset, is induced in the
Hyo Jung Lee   +7 more
doaj   +1 more source

Mechanisms of calcineurin inhibitor nephrotoxicity in chronic allograft injury

open access: yes, 2012
The first successful transplantation of a human kidney was performed more than 50 years ago by Murray and colleagues in 1954 between identical twins. The success of this transplantation was due to the fact that no significant rejection occurs between ...
Ryan, Michael P.   +10 more
core   +1 more source

Klotho is regulated by transcription factor Sp1 in renal tubular epithelial cells

open access: yesBMC Molecular and Cell Biology, 2020
Background Klotho is a multifunctional protein, which exists both in a membrane bound and a soluble form. In renal tubules, Klotho is involved in cell senescence, anti-oxidant response, and renal fibrosis, thus regulation of its expression is critical to
Yan Li   +14 more
doaj   +1 more source

Relationship between lysosomal dyshomeostasis and progression of diabetic kidney disease

open access: yesCell Death and Disease, 2021
Lysosomes are organelles involved in cell metabolism, waste degradation, and cellular material circulation. They play a key role in the maintenance of cellular physiological homeostasis.
Man Wu   +7 more
doaj   +1 more source

Chronic Kidney Disease – Where Next? : Predicting Outcomes And Planning Care Pathways [PDF]

open access: yes, 2014
Peer ...
Marks, Angharad   +5 more
core  

Home - About - Disclaimer - Privacy